180 related articles for article (PubMed ID: 2544354)
21. Oncogene amplification in tumor cells.
Alitalo K; Schwab M
Adv Cancer Res; 1986; 47():235-81. PubMed ID: 3022564
[No Abstract] [Full Text] [Related]
22. Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer.
Nau MM; Carney DN; Battey J; Johnson B; Little C; Gazdar A; Minna JD
Curr Top Microbiol Immunol; 1984; 113():172-7. PubMed ID: 6090062
[No Abstract] [Full Text] [Related]
23. Chromosomal abnormalities in a primary small cell lung cancer.
Sozzi G; Bertoglio MG; Borrello MG; Gianì S; Pilotti S; Pierotti M; Della Porta G
Cancer Genet Cytogenet; 1987 Jul; 27(1):45-50. PubMed ID: 3034398
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
[TBL] [Abstract][Full Text] [Related]
25. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
26. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
[TBL] [Abstract][Full Text] [Related]
27. p53: a frequent target for genetic abnormalities in lung cancer.
Takahashi T; Nau MM; Chiba I; Birrer MJ; Rosenberg RK; Vinocour M; Levitt M; Pass H; Gazdar AF; Minna JD
Science; 1989 Oct; 246(4929):491-4. PubMed ID: 2554494
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines.
Kern JA; Robinson RA; Gazdar A; Torney L; Weiner DB
Am J Respir Cell Mol Biol; 1992 Apr; 6(4):359-63. PubMed ID: 1312850
[TBL] [Abstract][Full Text] [Related]
29. Tumour markers and oncogenes in lung cancer.
Mäkelä TP; Mattson K; Alitalo K
Eur J Cancer; 1991; 27(10):1323-7. PubMed ID: 1659844
[No Abstract] [Full Text] [Related]
30. Amplification of oncogenes in lung carcinoma grafted in nude mice.
Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
[TBL] [Abstract][Full Text] [Related]
31. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers.
Taya Y
Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029
[TBL] [Abstract][Full Text] [Related]
32. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
[TBL] [Abstract][Full Text] [Related]
33. Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer.
Krystal G; Birrer M; Way J; Nau M; Sausville E; Thompson C; Minna J; Battey J
Mol Cell Biol; 1988 Aug; 8(8):3373-81. PubMed ID: 2850489
[TBL] [Abstract][Full Text] [Related]
34. Oncogene expression in small-cell lung cancer cell lines and a testicular germ-cell tumor: activation of the N-myc gene and decreased RB mRNA.
Saksela K; Mäkelä TP; Alitalo K
Int J Cancer; 1989 Jul; 44(1):182-5. PubMed ID: 2545635
[TBL] [Abstract][Full Text] [Related]
35. Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancer.
Mäkelä TP; Kere J; Winqvist R; Alitalo K
Mol Cell Biol; 1991 Aug; 11(8):4015-21. PubMed ID: 1649386
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
37. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
38. Molecular abnormalities in lung cancer.
Salgia R; Skarin AT
J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
[TBL] [Abstract][Full Text] [Related]
39. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.
Rodenhuis S; van de Wetering ML; Mooi WJ; Evers SG; van Zandwijk N; Bos JL
N Engl J Med; 1987 Oct; 317(15):929-35. PubMed ID: 3041218
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer.
Ojala A; Kallioniemi OP; Wigren T; Kallioniemi A; Mattila J; Lehtinen M; Koivula T
Acta Oncol; 1990; 29(8):983-8. PubMed ID: 2177611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
